Angiokeratoma regression in a Fabry disease after treatment with agalsidase-beta: clinical effectiveness marker? - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of the European Academy of Dermatology and Venereology Année : 2010

Dates et versions

hal-00595306 , version 1 (24-05-2011)

Identifiants

Citer

Anne-Laure Fauchais, S. Prey, B. Ouatara, Elisabeth Vidal, Agnès Sparsa. Angiokeratoma regression in a Fabry disease after treatment with agalsidase-beta: clinical effectiveness marker?. Journal of the European Academy of Dermatology and Venereology, 2010, 24 (6), pp.737-8. ⟨10.1111/j.1468-3083.2009.03455.x⟩. ⟨hal-00595306⟩
20 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More